Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „aflibercept“
Suchtreffer
Begriffe & Kennungen
Eiyzey · 4.3 · Hypersensitivity to the active substance aflibercept or to any of the excipients listed in section 6.1. Active
Eintrag öffnenEiyzey · 4.3 · Hypersensitivity to the active substance aflibercept or to any of the excipients listed in section 6.1. Active
Eintrag öffnenEiyzey · 4.5 · Adjunctive use of verteporfin photodynamic therapy (PDT) and aflibercept has not been studied, therefore, a sa
Eintrag öffnenEiyzey · 4.5 · Adjunctive use of verteporfin photodynamic therapy (PDT) and aflibercept has not been studied, therefore, a sa
Eintrag öffnenEiyzey · 4.8 · A low incidence rate of arterial thromboembolic events was observed in the aflibercept clinical trials in pati
Eintrag öffnenEiyzey · 4.8 · A low incidence rate of arterial thromboembolic events was observed in the aflibercept clinical trials in pati
Eintrag öffnenEiyzey · 4.8 · As with all therapeutic proteins, there is a potential for immunogenicity with aflibercept.
Eintrag öffnenEiyzey · 4.8 · As with all therapeutic proteins, there is a potential for immunogenicity with aflibercept.
Eintrag öffnenEiyzey · 4.8 · The most frequently observed adverse reactions (in at least 5% of patients treated with aflibercept) were conj
Eintrag öffnenEiyzey · 4.8 · The most frequently observed adverse reactions (in at least 5% of patients treated with aflibercept) were conj
Eintrag öffnenEydenzelt · 4.3 · Hypersensitivity to the active substance aflibercept or to any of the excipients listed in section 6.1. Active
Eintrag öffnenEydenzelt · 4.3 · Hypersensitivity to the active substance aflibercept or to any of the excipients listed in section 6.1. Active
Eintrag öffnenEydenzelt · 4.5 · Adjunctive use of verteporfin photodynamic therapy (PDT) and aflibercept has not been studied, 6 therefore,a s
Eintrag öffnenEydenzelt · 4.5 · Adjunctive use of verteporfin photodynamic therapy (PDT) and aflibercept has not been studied, therefore, a sa
Eintrag öffnenEydenzelt · 4.8 · The most frequently observed adverse reactions (in at least 5% of patients treated with aflibercept) were conj
Eintrag öffnenEydenzelt · 4.8 · The most frequently observed adverse reactions (in at least 5% of patients treated with aflibercept) were conj
Eintrag öffnenEylea · 4.3 · Hypersensitivity to the active substance aflibercept or to any of the excipients listed in section 6.1. Active
Eintrag öffnenEylea · 4.3 · Hypersensitivity to the active substance aflibercept or to any of the excipients listed in section 6.1. Active
Eintrag öffnenEylea · 4.8 · Adverse reactions reported in more than one patient treated with aflibercept 0.4 mg were retinal detachment, r
Eintrag öffnenEyluxvi · 4.3 · Hypersensitivity to the active substance aflibercept or to any of the excipients listed in section 6.1. Active
Eintrag öffnen